BOPI 07 BR/2023 REPERTOIRE NUMERIQUE 32 Fig. 1 Consulter le mémoire ________________________________________ (11) 21061 (51) A61K 39/00 (2018.01); A61K 39/12 (2018.01); A61K 45/06 (2018.01); A61K 48/00 (2018.01) ; A61P 31/14 (2018.01) (21) 1202200466 - PCT/EP2021/062250 (22) 10/05/2021 (30) EP n° 20173670.9 du 08/05/2020 (54) Parapoxvirus for conditioning for and treatment of coronavirus infections. (72) PAULSEN, Daniela (NL); BIRKMANN, Alexander (DE); LISCHKA, Peter (DE); PFAFF, Tamara (DE) et ZIMMERMANN, Holger (DE) (73) AICURIS GMBH & CO. KG, Friedrich-EbertStr. 475, 42117 WUPPERTAL (DE) (74) S.C.P AKKUM, AKKUM & Associates, n° 1777, Rue 6.261, Auditorium Jean Paul II, Quartier Mbankolo, B.P. 4966, YAOUNDE (CM). (57) The present invention relates to the treatment of coronavirus infections and to preparing subjects for such an infection by administering a parapoxvirus. This treatment is to assist the immune system in combatting the virus and to thereby prevent and to ameliorate symptoms of coronavirus disease. Fig. 4 Fig. 5 Consulter le mémoire
RkJQdWJsaXNoZXIy MTM1NDc3MA==